Cindy Castado

USPTO Granted Patents = 14 (Patent Applications = 14)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 14 (Patent Applications = 27)

Average Co-Inventor Count = 1.8

ph-index = 4

Forward Citations = 44(Granted Patents)

Company Filing History:

13 out of 531

Glaxosmithkline Biologicals Sa

Years Active: 2013-2022

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11466292 - Compositions and methods of treatment (2022-10-11),

2. 11266733 - Viral antigens (2022-03-08),

3. 10947280 - UspA2 protein constructs and uses thereof (2021-03-16),

4. 10745449 - UspA2 protein constructs and uses thereof (2020-08-18),

5. 10548963 - Immunogenic composition for use in vaccination against staphylococci (2020-02-04),

6. 10377816 - Nucleotide sequences, vectors and host cells (2019-08-13),

7. 10093722 - Nucleotide sequences, vectors and host cells (2018-10-09),

8. 10040832 - UspA2 protein constructs and uses thereof (2018-08-07),

9. 9669083 - Immunogenic composition comprising elements of C. difficile CDTb and/or CDTa proteins (2017-06-06),

10. 9644024 - Nucleotide sequences, vectors and host cells (2017-05-09),

11. 9567377 - Immunogenic composition (2017-02-14),

12. 9409974 - Immunogenic composition (2016-08-09),

13. 9290565 - Immunogenic composition (2016-03-22),

14. 8574596 - Pertussis antigens and use thereof in vaccination (2013-11-05),

Sure, I can create an article about inventor Cindy Castado for you.

Title: Cindy Castado - A Pioneer in the World of Inventions

Introduction:

Cindy Castado, a visionary inventor based in Rixensart, BE, is known for his passion for innovation and relentless drive to create a better future. His contributions to the field of inventions have positioned him as a true pioneer in the industry.

Latest Patents:

With an impressive portfolio of 14 patents, Cindy Castado’s recent inventions include groundbreaking compositions and methods of treatment. One of his latest patents focuses on nucleic acid constructs capable of encoding antigenic peptides derived from multiple Human Papilloma Virus (HPV) early proteins. These innovative compositions have significant potential in the treatment of persistent HPV infections and low-grade HPV lesions, particularly in human anogenital epithelial tissue.

Career Highlights:

Cindy Castado has made significant contributions to the field of biomedical research through his work at GlaxoSmithKline Biologicals SA and GlaxoSmithKline LLC. His innovative approach to vaccine development and treatment methods has garnered recognition within the industry.

Collaborations:

Throughout his career, Cindy Castado has collaborated with industry experts such as Jan Poolman and Normand Blais. These collaborations have led to the development of novel technologies and treatment solutions that have the potential to improve patient outcomes.

Conclusion:

In conclusion, Cindy Castado’s dedication to innovation and his remarkable achievements in the field of inventions showcase his commitment to creating a better future through groundbreaking research and development. His pioneering spirit serves as an inspiration to aspiring inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.